von Deetzen Marie-Charlotte, Schmeck Bernd T, Gruber Achim D, Klopfleisch Robert
Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag-Straße 15, 14163 Berlin, Germany.
Molecular Pulmonology, German Center for Lung Research, Philipps Universität Marburg, Hans-Meerwein-Straße 2, 35043 Marburg, Germany.
ISRN Vet Sci. 2014 Apr 2;2014:148597. doi: 10.1155/2014/148597. eCollection 2014.
MicroRNA has been suspected to be generally involved in carcinogenesis since their first description. A first study supported this assumption for canine mammary tumors when miRNA expression was compared to normal gland. The present study extends these results by comparing the expression of 16 microRNA (miRNA) and 4 small nucleolar RNA (snoRNA) in tumors of different malignancy, for example, adenomas, nonmetastasizing and metastasizing carcinomas as well as lymph node metastases, with each other and with normal mammary gland. All neoplastic tissues differed in their miR-210 expression levels from normal gland. While metastatic cells differed in their expression of mir-29b, miR-101, mir-125a, miR-143, and miR-145 from primary tumors, the comparison of miRNA expression in primary tumors of different malignancy failed to reveal significant differences except for a significant downregulation of mir-125a in metastasizing carcinomas when compared to adenomas.
自首次被描述以来,人们一直怀疑微小RNA普遍参与致癌过程。当将微小RNA的表达与正常腺体进行比较时,第一项研究支持了犬乳腺肿瘤的这一假设。本研究通过比较16种微小RNA(miRNA)和4种小核仁RNA(snoRNA)在不同恶性程度的肿瘤(例如腺瘤、非转移性和转移性癌以及淋巴结转移瘤)之间以及与正常乳腺组织之间的表达,扩展了这些结果。所有肿瘤组织的miR-210表达水平均与正常腺体不同。虽然转移细胞的mir-29b、miR-101、mir-125a、miR-143和miR-145表达与原发性肿瘤不同,但除了与腺瘤相比转移性癌中mir-125a显著下调外,不同恶性程度原发性肿瘤中微小RNA表达的比较未发现显著差异。